AMNN107

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMNN107, covering 2015-11-26 to 2015-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation [Phase 2]